BNBX
BNB Plus Corp.
NASDAQ · Healthcare · Biotechnology · US
$0.16
+0.00%Sep 3, 2026, 20:20 UTC
Robert B. Catell, Joseph D. Ceccoli and Dr. Yacov Shamash resigned as directors of BNB Plus Corp., effective September 3, 2026, and were succeeded by Richard Shorten, Todd Larsen and Lok Lee respectively.
Jul 30, 2026, 14:11 UTC
BNB Plus agreed to pay $1 million in cash and issue 200,000 preferred shares to Cypress LLC and Cypress Management LLC to settle and terminate their digital-asset management and strategic-adviser agreements, following Nasdaq's suspension of BNBX stock.
Source:Jun 3, 2026, 00:00 UTC
BNB PLUS CORP. issued 2,380,953 shares of Series B-1 Preferred Stock and common warrants in a private placement for gross proceeds of $2.5 million, and entered into warrant inducement and exchange agreements for additional proceeds of approximately $1.72 million.